medigraphic.com
SPANISH

Revista Cubana de Higiene y Epidemiología

ISSN 1561-3003 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2012, Number 2

<< Back Next >>

Rev Cubana Hig Epidemiol 2012; 50 (2)

Diabetes mellitus, obesity and renal function as coronary risk factors in adults aged over 15 from

Terroba CCJ, Dávila GHL, Malpica DJM, Robles MJA
Full text How to cite this article

Language: Spanish
References: 20
Page: 169-178
PDF size: 65.99 Kb.


Key words:

ischemic heart disease, risk factor, diabetes mellitus, obesity, chronic renal disease.

ABSTRACT

A case-control study was conducted throughout the year 2008 to identify the causal role of some ischemic heart disease risk factors in adults aged over 15 from La Demajagua People's Council on the Isle of Youth, Cuba. The sample was composed of 80 patients, of whom 40 were 1:1 paired for age and sex. Female sex, the 51-59 age range and a history of diabetes mellitus and obesity were found to be significant risk factors in the study sample, unlike reduced renal filtration, for which a causal relationship was not found. Obesity was the most significant coronary ischemia risk factor in the study group. The incidence of the disease would be reduced in about 35% if this risk factor could be either eliminated or controlled.


REFERENCES

  1. Pancobo Sandobal AE. Diagnóstico preventivo de la cardiopatía isquémica silente y de los factores de riesgo coronarios. Rehabilitación cardiovascular. Medicina del deporte y ciencias aplicadas al alto rendimiento y la salud. Caxias do Sul: EDUCS. 2002;1(1):495-543.

  2. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice: Fourth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil [Internet]. 2007;14(Suppl. 2):E1-E113. [cited: Jun 10 2012]. Available from: http://www.escardio.org/guidelines-surveys/esc-guidelines/GuidelinesDocuments/guidelines-CVD-prevention-ES-FT.pdf

  3. Agusti R. Factores de riesgo cardiovascular. Lima: Rev Per Cardiol [Internet]. 2005;31(14);3-7 [citado: 12 de junio de 2012]. Disponible en: http://sisbib.unmsm.edu.pe/BVRevistas/cardiologia/v31_n1/pdf/a01.pdf

  4. National Cholesterol Education Program. Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adult. Circulation [Internet]. 2002;106(25):3143-421 [cited: Jun 10 2012]. Available from: http://circ.ahajournals.org/content/106/25/3143.full.pdf+html

  5. Lim J, Tanuseputro P, Anderson GM, Alter DA, Laupacis A, et al. Revisiting Rose: strategies for reducing coronary heart disease. BMJ [Internet]. 2006332(7542):659-62 [cited: Mar 18 2012]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1403258/?tool=pubmed

  6. Gabriel R, Alonso MR, Segura A, Tormo MJ, Artigao LM, Banegas JR, et. al. Prevalencia, distribución y variabilidad geográfica de los principales factores de riesgo cardiovascular en España. Análisis agrupado de datos individuales de estudios epidemiológicos poblacionales: estudio ERICE. Rev Esp Cardiol [Internet]. 2012;61(10):1030-40 citado: 12 de junio de 2012]. Disponible en: http://www.revespcardiol.org/es/revistas/revista -espa%C3%B1ola-cardiologia-25/prevalencia-distribucion-variabilidad-geografica-los-principales-factores-13126043-epidemiologia-factores-riesgo-prevencion-2008

  7. Dirección Nacional de Epidemiología. Ministerio de Salud Pública. Programa Nacional de Prevención, Diagnóstico, Tratamiento y Rehabilitación de la Cardiopatía Isquémica. Dirección Nacional de Epidemiología. RESUMED [Internet]. 2001;14(4):157-9 [citado: 12 de junio de 2012]. Disponible en: http://bvs.sld.cu/revistas/res/vol14_4_01/res01401.htm

  8. Centro Municipal de Higiene, Epidemiología y Microbiología «Dr. Carlos J. Finlay». Informe Anual de Enfermedades no Transmisibles. Isla de la Juventud: CMHEM; 2004.

  9. Kannel WB. Cardioprotection and antihypertensive therapy: the key importance of addessing the associated coronary risk factors (the Framingham experience). Am J Cardiol. 1996;77(6):6B-11B.

  10. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic and cardiovascular risk. Arch Intern Med. 1993:153(5):598-615 [cited: Jun 12 2012]. Available from: http://archinte.ama-assn.org/cgi/content/abstract/153/5/598

  11. World Health Organization. Prevention of cardiovascular disease: guidelines for assessment and management of total cardiovascular risk. Geneva: WHO; 2007.

  12. Ordúñez P, Silva LC, Rodríguez MP, Robles S. Prevalence estimates for hypertension in Latin America and the Caribbean: are they useful for surveillance? Rev Panam Sal Publ. 2001;10(4):226-231 [cited: Jun 12 2012]. Available from: http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892001001000002

  13. Scottish Intercollegiate Guidelines Network (SIGN). Risk estimation and the prevention of cardiovascular disease. No.97. Edinburgh, UK: SIGN; c2001-2008 [cited: Jun 12 2012]. Available from: http://www.sign.ac.uk/pdf/sign97.pdf

  14. Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UK PDS 33). Diabetes Research Laboratories. Readcliffe infirmary. Lancet. 1998;352(9131):837-50.

  15. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-1053 [cited: Jun 12 2012]. Available from: http://care.diabetesjournals.org/content/27/5/1047.full

  16. Screening for Diabetes, American Diabetes Association. Diabetes Care. 2002;25(Suppl. 1):S21-S24 [cited: Jun 12 2012]. Available from: http://care.diabetesjournals.org/content/25/suppl_1/s21.full

  17. Shephard RJ. Absolute versus relative intensity of physical activity in a dose-response context. Med Sci Sports Exerc. 2001;33(6):400-18.

  18. Lizhohub VH, Hryshkova ZHA. Hemodynamic and metabolic disturbance in patients with hypertension with and without obesity. Lik Sprava 2002;3(4):38-42.

  19. Freitas JB, Tavares A, Kohlmann OJR, Zanella MT, Ribeiro AB. Cross-sectional study on blood pressure control in the department of nephrology of the Escola Paulista de Medicina- UNIFESP. Arq Bras Cardiol. 2002; 79(2):123-8.

  20. Rodríguez López L, Arencibia Echeverría FA, Serrano Morillo A, Cruz Moreno S. Factores de riesgo y complicaciones cardiovasculares en los pacientes bajo diálisis peritoneal. Rev Cubana Med Int Emerg. 2005; 4(1):16-23 [citado: 12 de junio de 2012]. Disponible en: http://bvs.sld.cu/revistas/mie/vol4_1_05/mie03105.pdf




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Hig Epidemiol. 2012;50